Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma

BACKGROUND: Perioperative therapy can improve the low survival benefit of surgery alone for locally advanced gastric cancer. The introduction of immunotherapy and its combination with chemotherapy and/or targeted therapy has created more opportunities for optimal treatment. The aim of the present st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yanan, Wang, Zhenqiang, Yan, Chao, Yan, Min, Hou, Zhiguo, Zheng, Rongrong, Zhu, Zhenggang, Li, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812167/
https://www.ncbi.nlm.nih.gov/pubmed/33490196
http://dx.doi.org/10.21037/atm-20-7802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812167/
https://www.ncbi.nlm.nih.gov/pubmed/33490196
http://dx.doi.org/10.21037/atm-20-7802

Ejemplares similares